Slender Sheath/Guiding Catheter Combination vs. Sheathless Guiding Catheter for Acute Coronary Syndrome: A Propensity-Matched Analysis of the Two Devices.


Journal

Journal of interventional cardiology
ISSN: 1540-8183
Titre abrégé: J Interv Cardiol
Pays: United States
ID NLM: 8907826

Informations de publication

Date de publication:
2020
Historique:
received: 27 05 2020
revised: 26 07 2020
accepted: 03 08 2020
entrez: 1 9 2020
pubmed: 31 8 2020
medline: 26 1 2021
Statut: epublish

Résumé

A Glidesheath slender (Terumo, Tokyo, Japan) and a sheathless Eaucath guiding catheter (Asahi Intecc, Nagoya, Japan) are two major slender devices utilized in percutaneous coronary intervention (PCI). This study aimed to investigate the differences in access-site complications between these devices in PCI for acute coronary syndrome (ACS). A total of 1108 consecutive patients who underwent transradial PCI for ACS were enrolled. Transradial PCI was performed using either a 7-Fr Glidesheath slender/7-Fr guiding catheter combination (Glidesheath group) or a 7.5-Fr sheathless guiding catheter (Sheathless group); 1 : 1 propensity score matching was performed, and 728 patients (364 in each group) were included in the propensity-matched population. In the matched patients, univariate analysis revealed that the Glidesheath group had less radial artery occlusion (RAO) at 30 days (Glidesheath: 1.4% vs. Sheathless: 4.1%, odds ratio (OR) = 0.33, 95% confidence interval (CI) =  0.12-0.91,

Identifiants

pubmed: 32863791
doi: 10.1155/2020/8216831
pmc: PMC7443233
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8216831

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Tsuyoshi Isawa et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Circ J. 2003 Oct;67(10):895-7
pubmed: 14578628
Ann Intern Med. 2015 Dec 15;163(12):932-40
pubmed: 26551857
Catheter Cardiovasc Interv. 1999 Feb;46(2):173-8
pubmed: 10348538
J Am Heart Assoc. 2016 Jan 25;5(1):
pubmed: 26811162
Can J Cardiol. 2014 Feb;30(2):211-6
pubmed: 24461923
Catheter Cardiovasc Interv. 2017 May;89(6):1014-1020
pubmed: 27567021
Catheter Cardiovasc Interv. 2010 Mar 1;75(4):596-602
pubmed: 20049959
Circ Cardiovasc Interv. 2016 Feb;9(2):e003129
pubmed: 26839392
Circulation. 2011 Jun 14;123(23):2736-47
pubmed: 21670242
Catheter Cardiovasc Interv. 2014 Sep 1;84(3):436-42
pubmed: 24285594
Catheter Cardiovasc Interv. 2008 Sep 1;72(3):357-364
pubmed: 18727126
J Hypertens. 1997 Dec;15(12 Pt 2):1659-64
pubmed: 9488219
Angiology. 2018 Oct;69(9):755-762
pubmed: 29504410
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E32-6
pubmed: 23785005
Can J Cardiol. 2016 Dec;32(12):1425-1432
pubmed: 27381263
EuroIntervention. 2021 Mar 19;16(16):1356-1358
pubmed: 31687932
EuroIntervention. 2018 Apr 20;13(17):2018-2025
pubmed: 28846541
Medicine (Baltimore). 2015 Dec;94(52):e2170
pubmed: 26717360

Auteurs

Tsuyoshi Isawa (T)

Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.

Kazunori Horie (K)

Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.

Taku Honda (T)

Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.

Masataka Taguri (M)

Department of Data Science, Yokohama City University School of Data Science, Yokohama, Japan.

Norio Tada (N)

Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH